Brassinosteroid-regulated transcription factors confer epigenetic changes that repress plant immunity

This study reveals that brassinosteroid-regulated transcription factors (CES and BEEs) repress plant immunity to prioritize growth by inducing DNA methylation changes at NLR gene loci, which alters pre-mRNA splicing through interactions with chromatin remodeling and splicing machinery.

The Gist

The Big Picture: The "Growth vs. Defense" Dilemma

Imagine a plant is like a small business. It has two main goals:

1. Grow and expand (make more leaves, flowers, and seeds).
2. Defend itself (fight off bugs, fungi, and diseases).

The problem is that you can't do both at 100% capacity at the same time. If the plant spends all its energy building a massive fortress (immunity), it stops growing. If it focuses only on growing, it might get eaten by a bug.

This plant needs a "manager" to decide when to switch between these modes. In this study, scientists discovered how a specific hormone called Brassinosteroid (BR) acts as that manager, and how a specific protein called CES acts as the foreman who carries out the orders.

The Main Characters

• Brassinosteroids (BRs): Think of these as the plant's "Growth Hormone." They tell the plant, "Hey, it's a nice day, let's grow big and strong!" But there's a catch: when the plant focuses on growth, it often ignores its defenses.
• CES (The Foreman): This is a protein that listens to the BRs. When BRs say "Grow!", CES gets to work to make sure the plant doesn't waste energy on unnecessary defenses.
• SNC1 (The Alarm System): This is a specific gene that acts like a super-sensitive smoke detector. If it's too sensitive, the plant thinks it's on fire even when it isn't, causing it to stop growing and stay small (autoimmunity).

The Discovery: How CES "Turns Down the Volume"

The scientists found that CES doesn't just tell the plant to ignore bugs; it actually changes the plant's "instruction manual" (DNA) and how those instructions are read. It does this in two clever ways:

1. The "Red Pen" on the DNA (Epigenetics)

Imagine the plant's DNA is a giant library of books. Some books contain instructions for building defenses.

• The Action: CES goes into the library and puts "Do Not Read" sticky notes (DNA methylation) on the pages of the defense books.
• The Result: The plant's machinery skips over these pages. It doesn't build the defense proteins, saving energy for growth.
• The Twist: When the plant doesn't have CES (like in the mutant plants studied), the "Do Not Read" notes are missing. The plant reads the defense books constantly, building up a massive army even when there are no enemies. This makes the plant very resistant to bugs, but it also makes the plant stunted and weak because it's wasting all its energy.

2. The "Edit Button" on the Instructions (Alternative Splicing)

Imagine the defense instructions are a movie script. Sometimes, the script has extra scenes that make the movie too long or confusing.

• The Action: CES works with a team of "editors" (splicing factors) to cut out specific scenes from the script of the SNC1 alarm gene.
• The Result: Instead of a full-length, super-sensitive alarm, the plant gets a "shortened" version of the alarm that is less sensitive. It won't go off for every little breeze.
• The Analogy: It's like taking a smoke detector that goes off when you toast bread and tweaking it so it only goes off when there's a real fire. This prevents the plant from panicking unnecessarily.

The "Double Agent" Connection

The study also found that the plant's growth hormone receptor (BRI1) and its immune system receptor (BAK1) are like double agents. They are the same person wearing two different hats.

• When the plant is growing, the "Growth Hat" is on.
• When a bug attacks, the "Defense Hat" is on.
• Because they share the same body, the plant has to choose. The study shows that CES helps the plant choose "Growth" by physically changing the DNA and editing the scripts of the defense genes.

Why Does This Matter?

1. Understanding Autoimmunity:
Just like humans can have autoimmune diseases where the body attacks itself, plants can get "autoimmune" if their defense system is too loud. This study shows how plants naturally calm that system down so they can grow.

2. Better Crops:
Farmers want crops that are big (high yield) but also tough (resistant to disease). Usually, you have to pick one or the other.

• If we understand exactly how CES works, scientists might be able to engineer crops that have the "best of both worlds." They could keep the defense genes "quiet" until a real bug attacks, then quickly "turn them up" without stunting the plant's growth.

The Bottom Line

This paper reveals a sophisticated "dimmer switch" in plants. The hormone Brassinosteroid tells the plant to grow. The protein CES listens to that signal and then:

1. Glues shut the pages of the defense manual (DNA methylation).
2. Edits the script of the alarm system (splicing).

This ensures the plant stays healthy and big, only fighting for its life when it absolutely has to. It's a perfect balance of growth and survival.

Technical Summary

1. Problem Statement

Plants face a fundamental trade-off between growth and immunity. Activating immune responses (such as those mediated by Nucleotide-Binding Leucine-Rich-Repeat receptors, or NLRs) is metabolically costly and often inhibits growth. While steroid hormones like brassinosteroids (BRs) are known to promote growth and suppress immunity, the specific molecular mechanisms linking BR signaling to the epigenetic and post-transcriptional repression of immune genes remain largely undefined. Specifically, it is unclear how BRs induce locus-specific DNA methylation changes and alternative splicing to fine-tune immune receptor activity without triggering constitutive autoimmunity.

2. Methodology

The study utilized Arabidopsis thaliana as the model system, employing a multi-omics approach combined with genetic and biochemical assays:

• Genetic Models: The study compared Wild Type (Col-0) with:
  • Gain-of-function (gof): ces-D (activation-tagged, constitutive CES expression) and 35S:CES-YFP (overexpression).
  • Loss-of-function (lof): ces bee1,3 triple mutant (ces-tM) and ces bee1,2,3 quadruple mutant (ces-qM).
  • Receptor mutants: bri1-1 (BR receptor null) and brl-tM (triple receptor mutant).
  • Immune mutants: snc1 (constitutively active NLR) and the double mutant ces-D × snc1.
• Pathogen Assays: Infection with Hyaloperonospora arabidopsidis (Hpa) isolate Noco2 to quantify resistance (spore counts, sporangiophore formation).
• Transcriptomics & Proteomics:
  • RNA-seq: Analyzed gene expression under basal and Hpa-infected conditions.
  • Proteomics: Mass spectrometry to validate protein abundance changes.
  • qPCR: Validated specific immune markers (e.g., PR1, PR2, PR5) and splice variants.
• Epigenomics:
  • Whole-Genome Bisulfite Sequencing (WGBS): Mapped DNA methylation (CG, CHG, CHH contexts) across the genome to identify Differentially Methylated Regions (DMRs).
  • ChIP-qPCR: Confirmed CES binding to the SNC1 locus.
• Biochemical Interactions:
  • Co-Immunoprecipitation (Co-IP) + LC-MS/MS: Identified proteins interacting with CES (specifically a SUMOylation-deficient mutant, CESAA, which accumulates in nuclear bodies).
  • Splicing Analysis: PCR and sequencing of cDNA to quantify SNC1 splice variants (isoforms).

3. Key Contributions & Results

A. CES Represses Immunity and Modulates SA Responses

• Phenotype: Overexpression of CES (ces-D) increased susceptibility to Hpa, while loss-of-function mutants (ces-qM) showed enhanced resistance.
• Transcriptome: CES acts as a negative regulator of a broad set of immune genes. In ces-qM, Salicylic Acid (SA)-responsive genes (e.g., PR1, PR2, PR5) and ROS-related genes were constitutively upregulated.
• Proteome: Proteomic analysis confirmed that the transcriptome changes translate to the protein level, with elevated levels of defense-related proteins in ces-qM.

B. CES Mediates DNA Methylation Reprogramming

• Global Methylation: WGBS revealed that CES drives widespread DNA methylation changes.
  • Hypo-methylation: Occurred in Transposable Element (TE)-rich regions (specifically CHH context) in ces-D.
  • Hyper-methylation: Occurred in gene bodies and promoters of adjacent genes (specifically CG context).
• Target Loci: These changes were most pronounced in NLR clusters, particularly the RPP5 cluster (containing SNC1, RPP4, SIKIC1/3).
• Mechanism: The methylation profile of ces mutants closely resembled that of drm2 (methyltransferase) and ros1 (demethylase) mutants, suggesting CES regulates the balance between methylation and demethylation, likely via the SWR1 chromatin remodeling complex and ROS1 recruitment.

C. CES Regulates Alternative Splicing of Immune Receptors

• Splicing Shifts: CES does not merely silence SNC1 transcription; it alters its alternative splicing.
  • In ces-D (high CES), the functional isoforms SNC1.1 and SNC1.2 were reduced, while a truncated, non-functional isoform (SNC1.3) predominated.
  • In ces-qM (low CES), functional isoforms accumulated.
• Protein Interaction: Co-IP/MS identified that CES physically associates with:
  • Chromatin remodelers: SWR1 complex subunits (SWC4, ARP4, RUVBL1/2).
  • Splicing machinery: MOS4-associated complex (MAC) components and spliceosome-associated proteins (e.g., SAP130B, SR factors).
• BR Dependence: The effect of CES on SNC1 splicing and methylation requires the BR receptor BRI1. In bri1 mutants, CES-induced methylation changes were attenuated, and SNC1 splicing patterns reverted toward wild-type.

D. Suppression of Autoimmunity

• Rescue of snc1: The snc1 mutant exhibits constitutive immunity and severe dwarfism due to over-accumulation of functional SNC1 isoforms.
• Double Mutant: Crossing ces-D with snc1 suppressed the dwarfism and restored normal growth. This occurred because high CES levels forced the splicing of SNC1 into the truncated, non-functional SNC1.3 isoform, effectively "turning off" the autoimmunity signal.

4. Significance

• Novel Mechanism of Hormone-Immunity Crosstalk: The study reveals a previously unrecognized mechanism where steroid hormones (BRs) utilize a specific transcription factor (CES) to repress immunity not just by transcriptional downregulation, but by coupling epigenetic remodeling (DNA methylation) with post-transcriptional regulation (alternative splicing).
• Growth-Defense Balance: This pathway allows plants to "prime" their immune system. By maintaining immune receptors in a repressed or spliced-inactive state under non-stress conditions, plants avoid the fitness costs of autoimmunity. Upon pathogen attack, this repression can be lifted to allow rapid defense activation.
• Therapeutic Potential: Understanding how CES links BR signaling to chromatin and splicing offers new targets for crop breeding. Modulating this pathway could potentially create crops with enhanced disease resistance without the typical growth penalties associated with constitutive immune activation.
• Broader Implications: The findings highlight the role of SUMOylation and nuclear body formation in coordinating chromatin state and RNA processing, a mechanism likely conserved across eukaryotes.

Conclusion

The paper establishes that the BR-regulated transcription factor CES acts as a central integrator that represses plant immunity by inducing CHH hypomethylation in TEs and CG hypermethylation in adjacent genes, which in turn drives the alternative splicing of NLR immune receptors (like SNC1) into non-functional variants. This mechanism allows plants to prioritize growth over defense in the absence of pathogens, providing a sophisticated layer of control over the growth-immunity trade-off.